Physician profile
Adam Kaplin
NPI 1871530006
$61,730.24
in general payments reported to CMS, 2019-2025
9 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $10K · 2021: $10K · 2022: $10K · 2023: $1,110 · 2024: $12K · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $1,098 · Travel and Lodging: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,815.00 |
| Food and Beverage | $1,098.22 |
| Travel and Lodging | $603.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $55,744.92 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $3,200.00 | 2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $2,194.00 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $244.53 | 2024-2025 | Caplyta |
| Abbvie INC. | $221.32 | 2024 | |
| Alkermes, INC. | $125.47 | 2024 | Lybalvi |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Kaplin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.